-
ACHV Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Achieve Life Sciences (ACHV)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm |
Cash burn (monthly) | 1.74 mm | 1.30 mm | 8.35 mm | 5.61 mm | 3.46 mm | 2.14 mm |
Cash used (since last report) | 7.94 mm | 5.93 mm | 38.17 mm | 25.66 mm | 15.81 mm | 9.80 mm |
Cash remaining | 1.62 mm | 3.64 mm | -28.61 mm | -16.10 mm | -6.24 mm | -234.44 k |
Runway (months of cash) | 0.9 | 2.8 | -3.4 | -2.9 | -1.8 | -0.1 |
13F holders | Current |
---|---|
Total holders | 72 |
Opened positions | 12 |
Closed positions | 6 |
Increased positions | 18 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 80.89 bn |
Total shares | 24.81 mm |
Total puts | 3.70 k |
Total calls | 131.90 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
BEN Franklin Resources | 3.87 mm | $19.32 bn |
Dialectic Capital Management | 3.54 mm | $0.00 |
Propel Bio Management | 2.45 mm | $11.63 bn |
BlackRock | 2.07 mm | $9.82 bn |
Contrarian Alpha | 1.98 mm | $11.18 mm |
Vanguard | 1.94 mm | $9.20 bn |
Sofinnova Investments | 1.51 mm | $7.18 bn |
Contrarian Achieve SPV | 1.32 mm | $3.15 mm |
Geode Capital Management | 749.11 k | $3.55 bn |
Nantahala Capital Management | 654.00 k | $3.10 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jan 25 | Cindy Jacobs | RSU Common Stock | Grant | Acquire A | No | No | 0 | 130,000 | 0.00 | 130,000 |
28 Jan 25 | Jaime Xinos | RSU Common Stock | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 100,000 |
28 Jan 25 | Jerry Wann | RSU Common Stock | Grant | Acquire A | No | No | 0 | 48,000 | 0.00 | 48,000 |
13 Jan 25 | Jaime Xinos | Stock Option Common Stock | Grant | Acquire A | No | No | 3.32 | 20,000 | 66.40 k | 20,000 |
13 Jan 25 | King Thomas Braxton | Stock Option Common Stock | Grant | Acquire A | No | No | 3.32 | 195,000 | 647.40 k | 195,000 |
13 Jan 25 | King Thomas Braxton | RSU Common Stock | Grant | Acquire A | No | No | 0 | 455,000 | 0.00 | 455,000 |